Characteristic | Total | LVI positive | LVI negative | P value | |||
---|---|---|---|---|---|---|---|
No. of patients | 85 | 24 | 61 | ||||
Age | 0.074 | ||||||
<70 years | 45 | (52.9%) | 9 | (37.5%) | 36 | (59.0%) | |
≥70 years | 40 | (47.1%) | 15 | (62.5%) | 25 | (41.0%) | |
Sex | 0.174 | ||||||
Male | 71 | (83.5%) | 22 | (91.7%) | 49 | (80.3%) | |
Female | 14 | (16.5%) | 2 | (8.3%) | 12 | (19.7%) | |
Tumor grade | 0.258 | ||||||
G1/2 | 4 | (4.7%) | 0 | (0.0%) | 4 | (6.6%) | |
G3 | 81 | (95.3%) | 24 | (100.0%) | 57 | (93.4%) | |
Concomitant CIS | 0.969 | ||||||
Positive | 21 | (24.7%) | 6 | (25.0%) | 15 | (24.6%) | |
Negative | 64 | (75.3%) | 18 | (75.0%) | 46 | (75.4%) | |
Multifocality | 0.905 | ||||||
Multiple | 61 | (71.8%) | 17 | (70.8%) | 44 | (72.1%) | |
Solitary | 24 | (28.2%) | 7 | (29.2%) | 17 | (27.9%) | |
History of Ta NMIBC | 0.563 | ||||||
Recurrence | 5 | (5.9%) | 1 | (4.2%) | 4 | (6.6%) | |
Primary | 80 | (94.1%) | 23 | (95.8%) | 57 | (93.4%) |